Trial: 201701084

A Phase II Study of Elotuzumab, Pomalidomide, & Dexamethasone (Elo-Pom-Dex) with Second Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma

Phase

II

Principal Investigator

Vij, Ravi

Disease Site

Bone Marrow Transplant; Multiple Myeloma

Learn more about this study at: clinicaltrials.gov